Abstract
BACKGROUND: Minor ailments contribute significantly to the burden on healthcare systems. The introduction of a Minor Ailment Service (MAS) may alleviate pressure from hospital Accident & Emergency departments by directing patients suffering from minor ailments to be managed within the community. Although MAS has demonstrated positive results internationally, its effectiveness and acceptability in Hong Kong have not been evaluated. This prospective observational study aims to evaluate the clinical and humanistic impacts of a MAS delivered by pharmacists at community pharmacies operated by non-governmental organisations (NGOs) in Hong Kong.
METHODS: Subjects were recruited using convenience sampling at eight NGO-operated community pharmacies. Patient-reported outcomes, including symptom resolution, satisfaction, and enablement, were collected using a follow-up questionnaire one week after MAS. Additionally, consultation records were matched and extracted from the Community Pharmacy Services System. Descriptive data analyses were conducted to evaluate the patient-reported outcomes after using MAS. Factors influencing the primary outcomes were assessed using mixed-effects linear and logistic regression models.
RESULTS: This study demonstrates that most subjects (95.1%) report improvement in their symptoms. The mean scores for the Pharmacy Services Questionnaire and Patient Enablement Instrument are 4.0 ± 0.8 out of 5 and 6.8 ± 3.2 out of 12, respectively. Minor ailments relating to the respiratory system are most frequently reported. Significant negative associations in symptom resolution, satisfaction, and enablement are mainly observed in patients suffering from central nervous system-related symptoms.
CONCLUSIONS: Patients receiving MAS provided by community pharmacists in community pharmacies report high levels of symptom resolution, satisfaction and enablement.
| Original language | English |
|---|---|
| Article number | 468 |
| Number of pages | 22 |
| Journal | Communications Medicine |
| Volume | 6 |
| Issue number | 1 |
| Early online date | 1 Jun 2026 |
| DOIs | |
| Publication status | Published - 31 Aug 2026 |
Bibliographical note
Copyright © The Author(s) 2026. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc-nd/4.0/Data Access Statement
Data in this study are available from the corresponding authors upon reasonable request.Funding
I.C.K.W. received research grants from Amgen, Janssen, GSK, Novartis, Pfizer, Bayer and Bristol-Myers Squibb and Takeda, Institute for Health Research in England, European Commission, National Health and Medical Research Council in Australia, The European Union’s Seventh Framework Programme for research, technological development, Research Grants Council Hong Kong and Health and Medical Research Fund Hong Kong; consulting fees from IQVIA and World Health Organization; payment for expert testimony for Appeal Court in Hong Kong; serves on advisory committees for Member of Pharmacy and Poisons Board; is a member of the Expert Committee on Clinical Events Assessment Following COVID-19 Immunization; is a member of the Advisory Panel on COVID-19 Vaccines of the Hong Kong Government; is the non-executive director of Jacobson Pharma Corp. Ltd. in Hong Kong; and is the founder and director of Therakind Limited (UK), Advance Data Analytics for Medical Science (ADAMS) Limited (HK) and OCUS Innovation Limited (HK, Ireland and UK).
Fingerprint
Dive into the research topics of 'Evaluating the Clinical and Humanistic Impact of a Self-Care and Minor Ailment Service (MAS)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver